Home
Browse All Titles
Sign In
Browse All Titles
The Maudsley Prescribing Guidelines in Psychiatry
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com
◀
*
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Z
▶
View All
Lactate in blood, psychotropic agent effects
Lamotrigine
clozapine augmentation
life-threatening cutaneous reactions
target range
borderline personality disorder
in overdose
restarting after period of non-compliance
Laxative misuse/abuse
Eating disorders
Biochemical and haematological effects of psychotropics
Laxatives
Clozapine: common adverse effects
Initiation of clozapine in the community
Acting on clozapine plasma concentration results
Clozapine-induced gastrointestinal hypomotility
Safer prescribing for physical conditions in dementia
Learning difficulties
capacity and consent
general considerations
prescribing practice
epilepsy comorbidity
Learning disabilities
Lemborexant
in overdose
use in patients with hepatic impairment
managing sleep disturbance in dementia
Leukopenia, psychotropic agent effects
Levomepromazine
Quick reference for licensed maximum doses
Relative adverse effects - a rough guide
Lewy body dementia
Dementia
Parkinson's disease
Libido
Linaclotide, for constipation treatment
Linear reductions of dose cause increasingly large reductions in effect on GABA-A receptor occupancy.
Lipoproteins in blood, psychotropic agent effects
Lisdexamfetamine
attention deficit hyperactivity disorder in adults
bulimia nervosa/binge eating disorder
borderline personality disorder
Lithium: prescribing and monitoring
Lithium use with
liver function tests (LFTs)
interpretation
monitoring to access drug effects
Lofepidrine, in overdose
Lone atrial fibrillation
Long-acting injectable antipsychotic medications - doses and frequencies
Long-acting oral antipsychotics
preventing sudden cessation
improving adherence
restarting after period of non-compliance
Loop diuretics, lithium interaction
Lorazepam
Acutely disturbed or violent behaviour
catatonia treatment
rapid tranquillisation of children and adolescents
Catatonia
concentration in normal dosing and UK legal limit
use in patients with hepatic impairment
low-density lipoprotein (LDL)
Loxapine
Relative adverse effects - a rough guide
Smoking and psychotropic drugs
Lumateperone
Antipsychotics - minimum effective doses
Psychotropics in overdose
Relative adverse effects - a rough guide
Equivalent doses
Quick reference for licensed maximum doses
Switching antipsychotics
Lack of engagement with psychological therapies
Legal issues
Less commonly used treatments, well supported by published evidence (no preference implied by order)
Levetiracetam, for tardive dyskinesia
Refresh
first
prev
1
2
30
select
next
last
Displaying items 1 - 30 of 44